optimark
mallinckrodt australia pty ltd - gadoversetamide -
prohance
bracco pty ltd - gadoteridol -
multihance
regional health ltd - gadobenate dimeglumine 0.529 g/ml equivalent to to 0.5 m gadobenic acid - solution for injection - 0.529 g/ml - active: gadobenate dimeglumine 0.529 g/ml equivalent to to 0.5 m gadobenic acid excipient: water for injection - multihance is a paramagnetic contrast agent for use in diagnostic magnetic resonance imaging (mri) of the liver and central nervous system (cns). multihance is indicated, for the detection of focal liver lesions in patients with known or suspected primary liver cancer (eg. hepatocellular carcinoma) or metastatic disease. multihance is also indicated for the mri of the brain and spine where it improves the detection of lesions and provides diagnostic information additional to that obtained with unenhanced mri. multihance is indicated for contrast enhance magnetic resonance angiography to improve the diagnostic accuracy of detecting clinical significant steno-occlusive vascular diseases in patients with known vascular diseases of the abdominal, supra-aortic or peripheral arteries.
prohance gadoteridol 2793mg/10ml injection vial
bracco pty ltd - gadoteridol, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; calteridol calcium; trometamol; sodium hydroxide; water for injections - do not freeze (syringe only). prohance is indicated for use in adults and children from 2 years of age for enhancement of magnetic resonance images of intracranial and spinal lesions where there is an abnormal blood-brain barrier or abnormal vascularity. prohance can also be used for whole body mri.
prohance solution
bracco imaging canada - gadoteridol - solution - 279.3mg - gadoteridol 279.3mg - other diagnostic agents
omniscan solution
ge healthcare canada inc - gadodiamide - solution - 287mg - gadodiamide 287mg - other diagnostic agents
gadovist 1.0 solution
bayer inc - gadobutrol - solution - 604.72mg - gadobutrol 604.72mg - other diagnostic agents
optimark solution
liebel-flarsheim canada inc - gadoversetamide - solution - 330.9mg - gadoversetamide 330.9mg - other diagnostic agents
vasovist solution
bayer inc - gadofosveset trisodium - solution - 244mg - gadofosveset trisodium 244mg - other diagnostic agents
ablavar solution
lantheus mi canada inc - gadofosveset trisodium - solution - 244mg - gadofosveset trisodium 244mg - other diagnostic agents